Stempoint Capital »

Immunocore Holdings Plc- shares owned by Stempoint Capital

Quarter-by-quarter ownership of Immunocore Holdings Plc- (IMCR) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Immunocore Holdings Plc-

Tip: Access up to 7 years of quarterly data

All positions including Immunocore Holdings Plc- held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunocore Holdings Plc- by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $12M 339k 33.89

More positions owned by Stempoint Capital

Syndax Pharmaceuticals (SNDX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Merus N V (MRUS)
Arcellx Common Stock (ACLX)
Amicus Therapeutics (FOLD)
Immunocore Hldgs Ads (IMCR)
Applied Therapeutics (APLT)
Merck & Co (MRK)
GSK Sponsored Adr (GSK)
Autolus Therapeutics Spon Ads (AUTL)
Cabaletta Bio (CABA)
Kalvista Pharmaceuticals (KALV)
Biohaven (BHVN)

View all positions for Stempoint Capital

Top funds holding Immunocore Holdings Plc-

Rtw Investments
Wellington Management Company
FMR
T. Rowe Price Investment Management
T. Rowe Price Associates
PRIMECAP Management Company
Baker Bros. Advisors
General Atlantic
Bellevue Group
Armistice Capital
Fiera Capital Corporation
BlackRock
Morgan Stanley
Braidwell
Pictet Asset Management Holding SA

View all funds holding Immunocore Holdings Plc-